ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort (CoEnv)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01314547
Recruitment Status : Completed
First Posted : March 14, 2011
Last Update Posted : October 15, 2012
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:
Susceptibility to SPA has been shown to be largely genetically determined. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Condition or disease
Spondylarthritis Primary Systemic Vasculitis

Detailed Description:
Susceptibility to SPA has been shown to be largely genetically determined but the contribution of environmental factors to disease evolution has not yet been elucidated. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Study Type : Observational
Actual Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
Study Start Date : March 2005
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2011



Primary Outcome Measures :
  1. Score on a disease activity rating scale [ Time Frame: Six years ]
    Score on a disease activity rating scale (quaterly,than monthly basis)


Secondary Outcome Measures :
  1. Ancillary studies will be possible with the available database [ Time Frame: six years ]
    Ancillary studies will be possible with the available database



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with SPA disease
Criteria

Inclusion Criteria:

  • 18 years SPONDILARTHRITIS: modified New York criteria Systemic vasculitis: ACR criteria

Exclusion Criteria:

no internet access


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01314547


Locations
France
hopital ambroise Pare
Boulogne, France, 92100
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: THOMAS HANSLIK, PU-PH Assistance Publique - Hôpitaux de Paris

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT01314547     History of Changes
Other Study ID Numbers: AOM02020
First Posted: March 14, 2011    Key Record Dates
Last Update Posted: October 15, 2012
Last Verified: November 2010

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Environment
spondylarthritis
vasculitis
stress
life event
vaccine

Additional relevant MeSH terms:
Vasculitis
Spondylarthritis
Systemic Vasculitis
Vascular Diseases
Cardiovascular Diseases
Spondylitis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases
Arthritis
Joint Diseases